Search
for
Sort by
Research 481–510 of 1000+
- Adult female acne: a guide to clinical practice
- Testosterone modulation of seizure susceptibility is mediated by neurosteroids 3α-androstanediol and 17β-estradiol
- Acne
- Xenobiotica-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models
- Androgenetic alopecia
- Immune and Non-immune Interactions in the Pathogenesis of Androgenetic Alopecia
- Pharmacogenetics of the Androgen Metabolic Pathway
- Cytochrome P450: A Target for Drug Development for Skin Diseases
- Pharmacology of Natural Volatiles and Essential Oils in Food, Therapy, and Disease Prophylaxis
- Telomere Dynamics and Telomerase in the Biology of Hair Follicles and their Stem Cells as a Model for Aging Research
- A population pharmacokinetic model for individualized regimens of finasteride according to CYP3A5 genotype and liver function
- Anti-inflammatory Effects in LPS-treated RAW 264.7 Cells and the Influences on Drug Metabolizing Enzyme Activities by the Traditional Herbal Formulas, Yongdamsagan-Tang and Paljung-san
- Intracrine androgen biosynthesis, metabolism and action revisited
- Defective trophoblast function in mice with a targeted mutation of Ets2
- Proteome Analysis of Human Hair Shaft
- Management of Hirsutism
- The antiinflammatory effects of Xuefu Zhuyu decoction on C3H/HeJ mice with alopecia areata
- Cytologic Atypia in a 53-Year-Old Man With Finasteride-Induced Gynecomastia
- Saw palmetto and finasteride in the treatment of category III prostatitis/chronic pelvic pain syndrome
- Female Pattern Hair Loss
- Finasteride promotes worsening of the cardiac deleterious effects of nandrolone decanoate and protects against genotoxic and cytotoxic damage
- Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression
- Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease‐associated psychological morbidity
- Association of biochemical hyperandrogenism with type 2 diabetes and obesity in Chinese women with polycystic ovary syndrome
- Clinical dose ranging studies with finasteride, a type 2 5α-reductase inhibitor, in men with male pattern hair loss
- Human type 3 5α-reductase is expressed in peripheral tissues at higher levels than types 1 and 2 and its activity is potently inhibited by finasteride and dutasteride
- A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer
- Hair corticosterone measurement in mouse models of type 1 and type 2 diabetes mellitus
- Finasteride, a Type 2 5α-reductase inhibitor, in the treatment of men with androgenetic alopecia
- PCOS in Adolescence and Type 2 Diabetes